13F filer · CIK 2012383 ↗
BlackRock
You are looking at Q4 2018. See the latest, Q2 2026 →
Reported value
$1.98T
−14% on the quarter before
Positions
5,018
234 new · 258 sold out
Top 10
14.3%
of the value
Est. gain
−$334.04B
on stocks held all quarter
Est. return
−14.9%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from BlackRock's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 25% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Cigna Corp New~$5.11BNew · 0.0% → 0.3%+26,892,201 shares
- Linde Plc~$4.83BNew · 0.0% → 0.2%+30,937,347 shares
- Tjx Cos Inc New~$2.14BAdded · 0.2% → 0.2%+47,939,993 shares
- Ishares Tr~$2.00BAdded · 0.2% → 0.3%+37,995,875 shares
- SPDR S&P 500 ETF TrCALL~$1.52BNew · 0.0% → 0.1%+6,062,800 underlying
- Verizon Communications Inc~$1.31BAdded · 0.6% → 0.9%+23,309,257 shares
- Exxon Mobil Corp~$1.16BAdded · 1.0% → 1.0%+16,949,332 shares
- Cvs Health Corp~$1.10BAdded · 0.3% → 0.3%+16,757,941 shares
- Marathon Pete Corp~$862.7MAdded · 0.1% → 0.2%+14,619,755 shares
- Merck & Co Inc~$788.2MAdded · 0.6% → 0.8%+10,315,510 shares
Largest sells
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$7.40BSold out · 0.3% → 0.0%−25,446,400 underlying
- Aetna Inc New~$4.73BSold out · 0.2% → 0.0%−23,339,226 shares
- Cigna Corporation~$3.51BSold out · 0.2% → 0.0%−16,870,482 shares
- Express Scripts Hldg Co~$3.38BSold out · 0.1% → 0.0%−35,572,234 shares
- Praxair Inc~$2.80BSold out · 0.1% → 0.0%−17,409,139 shares
- SPDR S&P 500 ETF TrCALL~$2.56BSold out · 0.1% → 0.0%−8,804,200 underlying
- Ishares Tr~$2.21BCut · 0.2% → 0.1%−20,796,371 shares
- Ishares Tr~$2.12BCut · 0.2% → 0.1%−15,257,832 shares
- Rockwell Collins Inc~$1.88BSold out · 0.1% → 0.0%−13,389,177 shares
- Dell Technologies Inc~$1.24BSold out · 0.1% → 0.0%−12,720,675 shares
Holdings
As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +0.6% · price −11.2% | 2.6% | $51.50B | −$6.45B | ||||||||
| AppleCOM · shares +0.3% · price −30.1% | 2.4% | $46.79B | −$20.11B | ||||||||
| AmazonCOM · shares +1.0% · price −25.0% | 2.0% | $38.76B | −$12.80B | ||||||||
| Johnson & JohnsonCOM · shares +1.9% · price −6.6% | 1.2% | $23.60B | −$1.64B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +2.9% · price −4.6% | 1.1% | $21.87B | −$1.03B | ||||||||
| Jpmorgan Chase & CoCOM · shares −1.1% · price −13.5% | 1.1% | $21.00B | −$3.27B | ||||||||
| AlphabetCAP STK CL C · shares +0.6% · price −13.2% | 1.0% | $20.32B | −$3.08B | ||||||||
| Pfizer IncCOM · shares +2.7% · price −1.0% | 1.0% | $20.20B | −$189.3M | ||||||||
| MetaCL A · shares −1.1% · price −20.3% | 0.99% | $19.62B | −$4.99B | ||||||||
| AlphabetCAP STK CL A · shares +0.05% · price −13.4% | 0.99% | $19.61B | −$3.04B | ||||||||
| Exxon Mobil CorpCOM · shares +6.3% · price −19.8% | 0.98% | $19.38B | −$4.50B | ||||||||
| Unitedhealth Group IncCOM · shares +3.6% · price −6.4% | 0.88% | $17.40B | −$1.14B | ||||||||
| Verizon Communications IncCOM · shares +8.4% · price +5.3% | 0.85% | $16.84B | +$781.8M | ||||||||
| Visa Inc.COM CL A · shares −0.5% · price −12.1% | 0.81% | $16.07B | −$2.21B | ||||||||
| Procter And Gamble CoCOM · shares +2.9% · price +10.4% | 0.78% | $15.48B | +$1.42B | ||||||||
| Merck & Co IncCOM · shares +5.6% · price +7.7% | 0.75% | $14.87B | +$1.01B | ||||||||
| Bank Amer CorpCOM · shares −0.3% · price −16.4% | 0.74% | $14.71B | −$2.88B | ||||||||
| IntelCOM · shares −0.5% · price −0.8% | 0.71% | $14.15B | −$108.6M | ||||||||
| CiscoCOM · shares −4.0% · price −10.9% | 0.71% | $14.01B | −$1.72B | ||||||||
| Chevron Corp NewCOM · shares +5.2% · price −11.0% | 0.70% | $13.91B | −$1.64B | ||||||||
| Wells Fargo Co NewCOM · shares +1.7% · price −12.3% | 0.69% | $13.62B | −$1.88B | ||||||||
| AT&TCOM · shares +4.0% · price −15.0% | 0.66% | $12.98B | −$2.20B | ||||||||
| MastercardCL A · shares −1.0% · price −15.3% | 0.61% | $12.11B | −$2.18B | ||||||||
| Coca Cola CoCOM · shares +2.9% · price +2.5% | 0.61% | $12.02B | +$286.1M | ||||||||
| Home Depot IncCOM · shares −1.5% · price −17.1% | 0.60% | $11.93B | −$2.45B | ||||||||
| Total · 5,018 positions | 100% | $1.98T | −$334.04B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 4,587 stocks held throughout, down $334.04B (−14.9%).
- Procter And Gamble Co+$1.42B+10%
- Merck & Co Inc+$1.01B+8%
- Verizon Communications Inc+$781.8M+5%
- Starbucks Corp+$618.4M+13%
- Eli Lilly+$562.8M+8%
- Meta−$4.99B−20%
- Nvidia−$5.74B−52%
- Microsoft−$6.45B−11%
- Amazon−$12.80B−25%
- Apple−$20.11B−30%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | $6.73T+18% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $5.72T−3% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $5.92T+4% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $5.71T+9% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $5.25T+10% | SEC ↗ |
| Q1 2025 | May 2, 2025 | $4.76T−4% | SEC ↗ |
| Q4 2024 | Feb 7, 2025 | $4.94T+4% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $4.76T+8% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $4.42T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $4.30T+10% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $3.92T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $3.48T−4% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $3.63T+7% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $3.39T+6% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $3.19T+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $2.94T−6% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $3.12T−16% | SEC ↗ |
| Q1 2022 | May 12, 2022 | $3.71T−6% | SEC ↗ |
| Q4 2021 | Feb 10, 2022 (amended) | $3.93T+10% | SEC ↗ |
| Q3 2021 | Nov 9, 2021 | $3.57T−1% | SEC ↗ |
| Q2 2021 | Aug 11, 2021 | $3.59T+6% | SEC ↗ |
| Q1 2021 | May 7, 2021 | $3.40T+9% | SEC ↗ |
| Q4 2020 | Feb 5, 2021 | $3.13T+16% | SEC ↗ |
| Q3 2020 | Nov 6, 2020 | $2.71T+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.51T+23% | SEC ↗ |
| Q1 2020 | May 1, 2020 | $2.04T−22% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $2.61T+10% | SEC ↗ |
| Q3 2019 | Nov 8, 2019 | $2.38T+2% | SEC ↗ |
| Q2 2019 | Aug 22, 2019 (amended) | $2.34T+4% | SEC ↗ |
| Q1 2019 | May 9, 2019 | $2.24T+13% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.98T−14% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $2.31T+6% | SEC ↗ |
| Q2 2018 | Aug 9, 2018 | $2.17T+4% | SEC ↗ |
| Q1 2018 | May 9, 2018 | $2.09T−0% | SEC ↗ |
| Q4 2017 | Feb 9, 2018 | $2.10T+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.98T+5% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.89T+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $1.82T+2,478% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $70.66B+1% | SEC ↗ |
| Q3 2016 | Nov 8, 2016 | $69.66B+5% | SEC ↗ |
| Q2 2016 | Aug 10, 2016 | $66.46B+7% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $62.17B | SEC ↗ |